Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results
CC transcript

EXPRESS SCRIPTS INC (ESRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2018 GN Akcea Announces Its Access and Distribution Strategy for TEGSEDI™ (inotersen)
07/12/2018 GN Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details
06/12/2018 GN Detailed Research: Economic Perspectives on Southern, AcelRx Pharmaceuticals, International Flavors & Fragrances, Pandora Media, Express Scripts Holding, and United Continental — What Drives Growth in Today's Competitive Landscape
04/13/2018 GN Express Scripts Holding Company Announces First Quarter 2018 Earnings Release Details
02/21/2018 GN Recent Analysis Shows EchoStar, Toro, Genesee & Wyoming, Express Scripts Holding, D.R. Horton, and Mirati Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth
01/15/2018 GN Express Scripts Holding Company Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
12/05/2017 GN New Research: Key Drivers of Growth for Express Scripts Holding, D.R. Horton, Mirati Therapeutics, EchoStar, Toro, and Genesee & Wyoming — Factors of Influence, Major Initiatives and Sustained Production
11/22/2017 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/20/2017 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/14/2017 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
11/06/2017 GN Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma – Emerging Consolidated Expectations, Analyst Ratings
09/05/2017 GN Express Scripts Holding Company Announces Third Quarter 2017 Earnings Conference Call
07/06/2017 GN Express Scripts Holding Company Announces Second Quarter 2017 Earnings Conference Call
04/11/2017 GN Express Scripts Holding Company Announces First Quarter 2017 Earnings Conference Call
06/30/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
06/29/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
02/24/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
02/22/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
02/12/2016 SC 13G Capital World Investors reports a 6.6% stake in Express Scripts, Incorporated
06/04/2014 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
06/02/2014 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
02/12/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/07/2012 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
12/07/2012 EFFECT Form EFFECT - Notice of Effectiveness
07/09/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
05/04/2012 PRN Express Scripts to Present at Bank of America Merrill Lynch Conference
04/12/2012 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
04/11/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/11/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/11/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/11/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/11/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/11/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/11/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy